Platshon Scott

EVP, Chief Business Officer

Platshon Scott has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 18, 2026.

On the most recent filing, Platshon Scott is listed as EVP, Chief Business Officer at Zymeworks Inc. Inside the rolling window, Platshon Scott reported no open-market purchases and 1 open-market sale totaling $382K in ZYME.

Companies traded

Other insiders at ZYME

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$382K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ZYMESale$382KNov 18SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Platshon Scott made?

Platshon Scott has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.

Which companies does Platshon Scott trade?

Platshon Scott has filed SEC Form 4 disclosures for 1 company, including ZYME.

When was Platshon Scott's most recent SEC Form 4 filing?

Platshon Scott's most recent SEC Form 4 filing on Tracefour is dated Nov 18, 2026.

What is Platshon Scott's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Platshon Scott is listed as EVP, Chief Business Officer.

What is Platshon Scott's total buy and sell value in the current window?

Inside the rolling retention window, Platshon Scott bought $0 and sold $382K based on SEC Form 4 filings.

What was Platshon Scott's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 15,292 ZYME shares on 2026-11-18, worth $382K, per SEC Form 4 filings.